Counsel to Pharma Company in Diabetes Drug Patent Litigation
Counseled a pharmaceutical company in an action before U.S. District Court for the Eastern District of North Carolina concerning its IP rights to an SGLT2 diabetes drug.
Counseled a pharmaceutical company in an action before U.S. District Court for the Eastern District of North Carolina concerning its IP rights to an SGLT2 diabetes drug.